Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer. (Record no. 30426635)

MARC details
000 -LEADER
fixed length control field 01467 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518074344.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202105s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1433-2981
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.clon.2019.11.010
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Reed, N
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210524
245 00 - TITLE STATEMENT
Title Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical oncology (Royal College of Radiologists (Great Britain))
Date of publication, distribution, etc. 05 2020
300 ## - PHYSICAL DESCRIPTION
Extent e145-e153 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Consensus
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Management
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug-Related Side Effects and Adverse Reactions
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Expert Testimony
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phenylurea Compounds
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinolines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thyroid Neoplasms
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Glen, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gerrard, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Good, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lei, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lyon, A R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Strachan, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wadsley, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Newbold, K
773 0# - HOST ITEM ENTRY
Title Clinical oncology (Royal College of Radiologists (Great Britain))
Related parts vol. 32
-- no. 5
-- p. e145-e153
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.clon.2019.11.010">https://doi.org/10.1016/j.clon.2019.11.010</a>
Public note Available from publisher's website

No items available.